• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医院内抗菌耐药菌的控制:全球医院的战略重点。

Control of nosocomial antimicrobial-resistant bacteria: a strategic priority for hospitals worldwide.

作者信息

Goldmann D A, Huskins W C

机构信息

Department of Pediatrics, Harvard Medical School, Boston, MA, USA.

出版信息

Clin Infect Dis. 1997 Jan;24 Suppl 1:S139-45. doi: 10.1093/clinids/24.supplement_1.s139.

DOI:10.1093/clinids/24.supplement_1.s139
PMID:8994794
Abstract

The rapid emergence and dissemination of antimicrobial-resistant microorganisms in hospitals worldwide is a problem of crisis dimensions. The root causes of this problem are multifactorial, but the core issues are clear. The emergence of antimicrobial resistance is highly correlated with selective pressure that results from inappropriate use of antimicrobial agents. Dissemination of resistant organisms is facilitated by person-to-person transmission due to inconsistent application of basic infection control practices by hospital personnel. While control strategies exist, the interventions are not likely to be successful unless hospital leaders assume the responsibility for control of antimicrobial resistance. Strategic goals for the control of resistant organisms should be formulated on the basis of multidisciplinary input from hospital personnel. Processes and outcomes relevant to these strategic goals should be measured, and the resultant data should be used to design, implement, and evaluate systematic measures to increase the appropriate use of antimicrobial agents and basic infection control practices. This approach is as relevant to hospitals in countries with limited resources as it is to in fully industrialized countries.

摘要

全球医院中抗菌药物耐药微生物的迅速出现和传播是一个具有危机规模的问题。这个问题的根源是多方面的,但核心问题很明确。抗菌药物耐药性的出现与抗菌药物使用不当导致的选择压力高度相关。医院工作人员基本感染控制措施应用不一致,通过人际传播促进了耐药菌的传播。虽然存在控制策略,但除非医院领导承担起控制抗菌药物耐药性的责任,否则这些干预措施不太可能成功。应根据医院工作人员的多学科意见制定控制耐药菌的战略目标。应衡量与这些战略目标相关的过程和结果,并将所得数据用于设计、实施和评估系统措施,以增加抗菌药物的合理使用和基本感染控制措施。这种方法对于资源有限国家的医院和完全工业化国家的医院同样适用。

相似文献

1
Control of nosocomial antimicrobial-resistant bacteria: a strategic priority for hospitals worldwide.医院内抗菌耐药菌的控制:全球医院的战略重点。
Clin Infect Dis. 1997 Jan;24 Suppl 1:S139-45. doi: 10.1093/clinids/24.supplement_1.s139.
2
Strategies to Prevent and Control the Emergence and Spread of Antimicrobial-Resistant Microorganisms in Hospitals. A challenge to hospital leadership.预防和控制医院中抗菌药物耐药微生物出现与传播的策略。对医院领导层的一项挑战。
JAMA. 1996 Jan 17;275(3):234-40.
3
Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC).预防万古霉素耐药性传播的建议。医院感染控制实践咨询委员会(HICPAC)的建议。
MMWR Recomm Rep. 1995 Sep 22;44(RR-12):1-13.
4
Antibiotic stewardship in the intensive care unit.重症监护病房的抗生素管理
Crit Care. 2014 Aug 13;18(5):480. doi: 10.1186/s13054-014-0480-6.
5
Implementation of strategies to control antimicrobial resistance.控制抗菌药物耐药性策略的实施
Chest. 2001 Feb;119(2 Suppl):405S-411S. doi: 10.1378/chest.119.2_suppl.405s.
6
For nosocomial vancomycin-resistant enterococcal infections: the ounce of prevention or the pound of cure?对于医院获得性耐万古霉素肠球菌感染:是预防为主还是治疗为主?
Clin Infect Dis. 2004 Apr 15;38(8):1116-8. doi: 10.1086/382891. Epub 2004 Apr 5.
7
Vancomycin-resistant enterococcal infections in Korea.韩国的耐万古霉素肠球菌感染
Yonsei Med J. 1998 Dec;39(6):562-8. doi: 10.3349/ymj.1998.39.6.562.
8
New aspects of antimicrobial resistance and the resulting therapeutic dilemmas.抗菌药物耐药性的新情况及由此产生的治疗困境。
J Infect Dis. 1991 Jun;163(6):1184-94.
9
Vancomycin-resistant enterococci.耐万古霉素肠球菌。
Crit Care Clin. 2013 Oct;29(4):841-52. doi: 10.1016/j.ccc.2013.06.006.
10
Hospital-acquired infections: diseases with increasingly limited therapies.医院获得性感染:治疗方法日益有限的疾病。
Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2420-7. doi: 10.1073/pnas.91.7.2420.

引用本文的文献

1
Amino Acids in the Development of Prodrugs.氨基酸在前药开发中的作用。
Molecules. 2018 Sep 11;23(9):2318. doi: 10.3390/molecules23092318.
2
Global Antimicrobial Stewardship: A Closer Look at the Formidable Implementation Challenges.全球抗菌药物管理:深入审视严峻的实施挑战
Front Microbiol. 2016 Nov 16;7:1860. doi: 10.3389/fmicb.2016.01860. eCollection 2016.
3
Nosocomial Infections and Epidemiology of Antibiotic Resistance in Teaching Hospitals in South East of Iran.伊朗东南部教学医院的医院感染与抗生素耐药性流行病学
Glob J Health Sci. 2015 Jun 25;8(2):190-7. doi: 10.5539/gjhs.v8n2p190.
4
An agent-based simulation model for Clostridium difficile infection control.一种基于主体的艰难梭菌感染控制模拟模型。
Med Decis Making. 2015 Feb;35(2):211-29. doi: 10.1177/0272989X14545788. Epub 2014 Aug 11.
5
Impact of enhanced infection control at 2 neonatal intensive care units in the Philippines.菲律宾两家新生儿重症监护病房加强感染控制的影响。
Clin Infect Dis. 2009 Jan 1;48(1):13-21. doi: 10.1086/594120.
6
Trends of methicillin-resistant Staphylococcus aureus (MRSA) and Enterobacteriaceae-producing extended-spectrum beta-lactamase (ESBLE) in eastern France: a three-year multi-centre incidence study.法国东部耐甲氧西林金黄色葡萄球菌(MRSA)和产超广谱β-内酰胺酶肠杆菌科细菌(ESBLE)的流行趋势:一项为期三年的多中心发病率研究。
Eur J Clin Microbiol Infect Dis. 2008 Nov;27(11):1113-7. doi: 10.1007/s10096-008-0536-0. Epub 2008 May 17.
7
Choice of antibiotics in late neonatal sepsis in the extremely low birth weight infant.极低出生体重儿晚期新生儿败血症抗生素的选择
Can J Infect Dis. 2003 Jan;14(1):28-31. doi: 10.1155/2003/510265.
8
Antimicrobial resistance among commensal isolates of Escherichia coli and Staphylococcus aureus in the Indonesian population inside and outside hospitals.印度尼西亚医院内外人群中大肠杆菌和金黄色葡萄球菌共生分离株的抗菌药物耐药性
Eur J Clin Microbiol Infect Dis. 2008 Jan;27(1):45-51. doi: 10.1007/s10096-007-0396-z. Epub 2007 Oct 13.
9
Analysis of vancomycin use and associated risk factors in a university teaching hospital: a prospective cohort study.大学教学医院中万古霉素使用情况及其相关危险因素分析:一项前瞻性队列研究。
BMC Infect Dis. 2007 Aug 1;7:88. doi: 10.1186/1471-2334-7-88.
10
Discrepancies between prescribed daily doses and WHO defined daily doses of antibacterials at a university hospital.某大学医院抗菌药物规定日剂量与世界卫生组织定义日剂量之间的差异。
Br J Clin Pharmacol. 2006 May;61(5):585-91. doi: 10.1111/j.1365-2125.2006.02605.x.